These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21157823)
1. Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia-inducible gene expression system. Liu ML; Oh JS; An SS; Pennant WA; Kim HJ; Gwak SJ; Yoon DH; Kim KN; Lee M; Ha Y J Gene Med; 2010 Dec; 12(12):990-1001. PubMed ID: 21157823 [TBL] [Abstract][Full Text] [Related]
2. Neural stem cells modified by a hypoxia-inducible VEGF gene expression system improve cell viability under hypoxic conditions and spinal cord injury. Lian Jin H; Pennant WA; Hyung Lee M; Su S; Ah Kim H; Lu Liu M; Soo Oh J; Cho J; Nyun Kim K; Heum Yoon D; Ha Y Spine (Phila Pa 1976); 2011 May; 36(11):857-64. PubMed ID: 21192293 [TBL] [Abstract][Full Text] [Related]
3. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury. Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-specific, VEGF-expressing neural stem cell therapy for safe and effective treatment of neuropathic pain. Lee HL; Lee HY; Yun Y; Oh J; Che L; Lee M; Ha Y J Control Release; 2016 Mar; 226():21-34. PubMed ID: 26826306 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury. Kim HJ; Oh JS; An SS; Pennant WA; Gwak SJ; Kim AN; Han PK; Yoon DH; Kim KN; Ha Y Gene Ther; 2012 May; 19(5):513-21. PubMed ID: 22011644 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of erythropoietin enhancer-mediated hypoxia-inducible gene expression by co-transfection of a plasmid encoding hypoxia-inducible factor 1alpha for ischemic tissue targeting gene therapy. Lee S; Kim K; Kim HA; Kim SW; Lee M J Drug Target; 2008 Jan; 16(1):43-50. PubMed ID: 18172819 [TBL] [Abstract][Full Text] [Related]
7. Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy. Jin H; Liu ML; Kim HA; Lee M; An S; Oh J; Cho J; Yi S; Kim K; Yoon D; Ha Y Spine (Phila Pa 1976); 2009 Dec; 34(26):E952-8. PubMed ID: 20010384 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy. Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy with an erythropoietin enhancer-mediated, hypoxia-inducible gene expression system in the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction. Ryu JK; Lee M; Choi MJ; Kim HA; Jin HR; Kim WJ; Yin GN; Song KM; Kwon MH; Suh JK J Androl; 2012; 33(5):845-53. PubMed ID: 22403284 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model. Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488 [TBL] [Abstract][Full Text] [Related]
11. Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system. Lee M; Lee ES; Kim YS; Choi BH; Park SR; Park HS; Park HC; Kim SW; Ha Y Spine (Phila Pa 1976); 2005 Dec; 30(24):2729-34. PubMed ID: 16371895 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944 [TBL] [Abstract][Full Text] [Related]
13. Characterization of neural stem cells modified with hypoxia/neuron-specific VEGF expression system for spinal cord injury. Yun Y; Oh J; Kim Y; Kim G; Lee M; Ha Y Gene Ther; 2018 Jan; 25(1):27-38. PubMed ID: 29155421 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP). Kim JM; Lee M; Kim KH; Ha Y; Choi JK; Park SR; Park H; Park HC; Ahn CH; Kim SW; Choi BH J Control Release; 2009 Jan; 133(1):60-7. PubMed ID: 18938203 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domain. Kim HA; Kim K; Kim SW; Lee M J Control Release; 2007 Aug; 121(3):218-24. PubMed ID: 17628167 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-specific VEGF-expressing neural stem cells in spinal cord injury model. Oh JS; An SS; Gwak SJ; Pennant WA; Kim KN; Yoon DH; Ha Y Neuroreport; 2012 Feb; 23(3):174-8. PubMed ID: 22186804 [TBL] [Abstract][Full Text] [Related]
17. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy. Kim HA; Park JH; Yi N; Lee M Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192 [TBL] [Abstract][Full Text] [Related]
18. A Gene and Neural Stem Cell Therapy Platform Based on Neuronal Cell Type-Inducible Gene Overexpression. Oh J; You Y; Yun Y; Lee HL; Yoon DH; Lee M; Ha Y Yonsei Med J; 2015 Jul; 56(4):1036-43. PubMed ID: 26069128 [TBL] [Abstract][Full Text] [Related]
19. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model. Choi M; Oh J; Rhim T; Lee M Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961 [TBL] [Abstract][Full Text] [Related]
20. Antiapoptotic Effect of Highly Secreted GMCSF From Neuronal Cell-specific GMCSF Overexpressing Neural Stem Cells in Spinal Cord Injury Model. You Y; Che L; Lee HY; Lee HL; Yun Y; Lee M; Oh J; Ha Y Spine (Phila Pa 1976); 2015 Dec; 40(24):E1284-91. PubMed ID: 26230539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]